Naloxone manufacturer Hospira issued a voluntary recall of its single-use cartridge syringe system for the opioid overdose antidote.
Package labeling recommends visual inspection to detect the presence of discoloration or particulates before administration, which would diminish the risks for using these lots.More news: 76ers owners reportedly discuss Colangelo future
The company says it found loose particulate matter on the syringe plunger. Patients who come into contact with the particulate matter may suffer from the following local irritation, allergic reactions, phlebitis, end-organ granuloma, tissue ischemia, pulmonary emboli, pulmonary dysfunction, pulmonary infarction, and toxicity.
Hancock Public Health, which provides naloxone kits to the community, says its kits are not affected by a nationwide recall.
A Rockford firefighter displays a dose of Naloxone which the department carries on their ambulances to treat opioid drug overdoses on July 14, 2017 in Rockford, Illinois.More news: The Moon's Gradual Retreat is Lengthening Earth Days
Naloxone is also available in the intravenous form, intramuscular, and subcutaneous.
The CDC released a report in March that shows that 115 Americans are dying every day from the opioid epidemic. "Hospira, Inc., has notified wholesalers/distributors/hospitals to arrange for return of any recalled product". Nationwide, an estimated 60,000 people in the US died from drug overdoses in 2016, more than gunshots or traffic accidents. The drug is known to restore the respiration to a person who stops breathing due to the overdose.More news: Warriors close on title as Kevin Durant heroics beat Cavaliers
- Trump hosts first White House Iftar dinner, several Muslim groups boycott
- Palestinian man shot dead for throwing stone at IDF soldier
- Father of Irish Olympic champion Katie Taylor shot at boxing club
- Multiple US diplomats in China hit by mystery illness: State Dept.
- Salad days are over ... now Heinz labels it Sandwich Cream
- Trump suggests political bias to blame in Clinton email report's delay
- LeBron, Curry, Durant say National Basketball Association champ won't go to White House
- Andre Iguodala has 'good chance' to play Game 3
- OAS calls extraordinary assembly to vote on suspending Venezuela
- Calls grow in Germany for expulsion of disputed US ambassador